Buprenorphine for Chronic Pain Management in Sickle Cell Disease
The Primary Care Companion For CNS Disorders · 16.06.2026 · 28 (3)
DOI: 10.4088/pcc.25r04126 ↗Kurz gefasst
Scoping Review in der Zeitschrift The Primary Care Companion For CNS Disorders, online erschienen am 16.06.2026. Verfasst von Satneet Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Division Of Addiction Psychiatry, University of Kansas Medical Center, Kansas City, Kansas. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Buprenorphine, Chronic Pain, Analgesics, Opioid.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Division Of Addiction Psychiatry, University of Kansas Medical Center, Kansas City, Kansas.
- Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.
- Corresponding Author: Roopa Sethi, MD, Department of Addiction Psychiatry, University of Kansas Medical Center, Kansas City, KS 66160 (rsethi@kumc.edu).
Zitieren
APA
Singh, S., Akbari, A. R., Marín-López, C., Perchellet, M., & Sethi, R. (2026). Buprenorphine for Chronic Pain Management in Sickle Cell Disease. The Primary Care Companion For CNS Disorders, 28(3). https://doi.org/10.4088/pcc.25r04126
Vancouver
Singh S, Akbari AR, Marín-López C, Perchellet M, Sethi R. Buprenorphine for Chronic Pain Management in Sickle Cell Disease. The Primary Care Companion For CNS Disorders. 2026;28(3). doi:10.4088/pcc.25r04126
BibTeX
@article{Singh2026,
author = {Singh, Satneet and Akbari, Amir Reza and Marín-López, Carlos and Perchellet, Melissa and Sethi, Roopa},
title = {Buprenorphine for Chronic Pain Management in Sickle Cell Disease},
journal = {The Primary Care Companion For CNS Disorders},
year = {2026},
volume = {28},
number = {3},
doi = {10.4088/pcc.25r04126}
}
EUVIMED